LVP LIFE SCIENCE VENTURES III L.P. 13D and 13G filings for Viracta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-03-05 1:30 pm Purchase | 2021-02-25 | 13G | Viracta Therapeutics, Inc. VIRX | LVP LIFE SCIENCE VENTURES III L.P. | 3,124,094 8.440% | 3,124,094 (New Position) | Filing |
| 2021-03-03 7:22 pm Purchase | 2021-02-25 | 13G | Viracta Therapeutics, Inc. VIRX | LVP LIFE SCIENCE VENTURES III L.P. | 3,124,094 8.440% | 3,124,094 (New Position) | Filing |